Ekso Is Set to Conquer the Most Valuable Unstoppable Trend of All (OTCBB: EKSO)

A year ago, Ekso Bionics (OTCBB: EKSO) was almost completely off the radar and totally unknown to both investors and analysts alike. But we knew that wouldn't be the case for long. We also knew the company would attract a lot more capital down the road once others saw the potential... as long as management continued to produce results. And that's precisely what EKSO'S done - it's produced, and continues to produce, major results. Here's why you need you need this company's stock in your portfolio ASAP... Tags: biotechnology stock , construction industry , construction sector , construction stock , Ekso Bionics stock , Ekso labs , human augmentation stock , human exoskeletons , medicine industry , medicine stock , OTCBB: EKSO To get full access to all Money Morning content, click here About Money Morning: Money Morning gives you access to a team of ten market experts with more than 250 years of combined investing experience – for free . Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and Moneymorning.com visitors become smarter, more confident investors. Disclaimer: © 2015 Money Morning and Money Map Press. All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning. 16 W. Madison St. Baltimore, MD, 21201. The post Ekso Is Set to Conquer the Most Valuable Unstoppable Trend of All (OTCBB: EKSO) appeared first on Money Morning - We Make Investing Profitable .
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.